Rapporto di analisi sulle dimensioni e le previsioni del mercato europeo della nutrizione enterale (2021-2031), quota regionale, tendenza e opportunità di crescita: per tipo di prodotto (nasogastrico, nasoenterale, sorseggiabile e altri) e paese
Formulazioni standardizzate e prodotti nutrizionali a base vegetale
C\'è un\'impennata nella domanda di prodotti che aiutino i consumatori a gestire in modo proattivo la propria salute, in particolare quelli focalizzati su esigenze specifiche in termini di livelli di energia, immunità e trattamento delle malattie. La funzionalità e le formulazioni specifiche dei prodotti enterali non interferiscono con i trattamenti esistenti dei pazienti. Le formulazioni di macronutrienti e micronutrienti della nutrizione enterale e le loro applicazioni variano in base alla malattia in esame. La formulazione di nutrizione enterale isocalorica (1 kcal/ml) è generalmente prescritta per raggiungere obiettivi calorici stimati o misurati, mentre le formule ad alta densità energetica (>1 kcal/ml) sono prescritte per aumentare l\'apporto calorico nei pazienti con disfunzione gastrointestinale.
I prodotti di nutrizione enterale standardizzati contengono costituenti fissi e sono progettati per soddisfare i requisiti nutrizionali medi dei pazienti, considerando che i requisiti differiscono nelle diverse fasce d\'età. Ad esempio, la formula Peptamen (Nestle) è l\'unica formula a base di peptidi con proteine del siero del latte al 100% idrolizzate enzimaticamente che aiuta a superare l\'intolleranza all\'alimentazione tramite sondino. Tali formule per l\'alimentazione tramite sondino sono prodotti di nutrizione enterale specializzati progettati per supportare l\'assorbimento e superare i meccanismi di tolleranza negli individui con disturbi gastrointestinali.
Un aumento del numero di persone che si rivolgono ad alimenti di origine vegetale innesca la domanda di prodotti di nutrizione di origine vegetale in tutto il mondo. Le persone stanno diventando sempre più intolleranti agli ingredienti artificiali/di origine sintetica utilizzati in quantità maggiori, il che può portare a reazioni avverse. L\'indagine Innova Consumer Survey 2020 ha mostrato che salute, varietà di dieta, sostenibilità e gusto sono tra i principali motivi per cui le persone prendono in considerazione alternative a base vegetale. Abbott afferma che anche i consumatori e i pazienti che si affidano all\'alimentazione tramite sondino prestano molta attenzione a questi parametri. Le aziende nel mercato europeo della nutrizione enterale stanno capitalizzando la crescente preferenza per cibi sani in vari gruppi demografici. Di conseguenza, aziende come Kate Farms, Functional Formularies e Real Food Blends hanno sviluppato prodotti enterali più naturali a base vegetale. Ad agosto 2021, Kate Farms ha lanciato il primo sistema di alimentazione chiuso che fornisce formule a base vegetale in sacchetti pronti da appendere da 1 L di capacità. Le formulazioni Kate Farms Standard 1.4 plain e Peptide 1.5 plain sono prodotti vegetali, biologici e caloricamente densi che vengono utilizzati come unica fonte di nutrizione supplementare nell\'alimentazione tramite sondino. A settembre 2021, Abbott ha introdotto un portafoglio di proteine vegetali e ingredienti alimentari biologici per bambini e adulti.
Pertanto, le formulazioni funzionali incentrate sul paziente e i prodotti nutrizionali a base vegetale sono le principali tendenze emergenti nel mercato europeo della nutrizione enterale.
Analisi del mercato della nutrizione enterale in Francia
Secondo un articolo di Le Monde pubblicato a marzo 2023, si prevede che la quota di popolazione di persone di età pari o superiore a 60 anni in Francia aumenterà da circa il 20% nel 2023 a circa il 30% entro il 2050. Il numero di persone di età pari o superiore a 85 anni crescerà di quasi il 90% nel periodo 2030-2050. Gli anziani spesso soffrono di condizioni croniche come diabete, malattie cardiovascolari e disturbi neurologici (ad esempio, ictus, morbo di Parkinson e Alzheimer). Queste condizioni possono compromettere la capacità di mangiare normalmente, portando a malnutrizione e richiedendo l\'alimentazione enterale. Secondo il Global Cancer Observatory, la Francia ha segnalato 483.568 nuovi casi di cancro nel 2022 e il numero di casi prevalenti (5 anni) è stato di 1.494.814. Cancro e nutrizione enterale sono strettamente collegati. Molti pazienti oncologici soffrono di malnutrizione a causa della malattia stessa o dei trattamenti che ricevono, che possono compromettere la loro capacità di mangiare e assorbire i nutrienti essenziali.
Fresenius Kabir France offre un portafoglio diversificato di prodotti per la nutrizione enterale pronti all\'uso come alimenti per sondino, integratori alimentari orali (ONS) e prodotti in polvere. Per i pazienti con disfagia, l\'azienda offre prodotti con consistenza modificata in diverse consistenze per soddisfare le esigenze individuali di diversi pazienti.
Analisi della segmentazione del rapporto sul mercato della nutrizione enterale in Europa
I segmenti chiave che hanno contribuito alla derivazione dell\'analisi del mercato della nutrizione enterale in Europa sono tipo, materiale e utente finale.
In base al tipo di prodotto, il mercato europeo della nutrizione enterale è suddiviso in Nasogastric, Nasoenteral, Sipping e altri. Il segmento nasogastrico ha detenuto la quota maggiore del mercato nel 2023.
Alcuni importanti attori che operano nel mercato europeo della nutrizione enterale sono Nestlé, Danone SA, Abbott Laboratories, Friesland Campina, Fresenius SE and Co. KGaA, B. Braun SE, Dr. Schär AG, Arla Food, Reckitt Benckiser, Perrigo Company PLC, Fonterra Co-operative Group Limited, Kate Farms e Nutritional Medicinals, LLC, tra gli altri.
Le aziende stanno lanciando prodotti e servizi nuovi e innovativi per sostenere la propria posizione nelle dimensioni del mercato europeo della nutrizione enterale. A novembre 2021, Abbott ha lanciato Similac 360 Total Care per supportare il sistema immunitario, la salute digestiva e lo sviluppo del cervello. Similac 360 Total Care è la prima e unica formula per neonati negli Stati Uniti con una miscela di cinque diversi HMO, precedentemente presenti solo insieme nel latte materno. Questa formula è progettata per fornire nutrimento per supportare la salute e lo sviluppo dell\'intero bambino, inclusi il sistema immunitario in via di sviluppo, l\'apparato digerente e il cervello.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Europe Enteral Nutrition Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Pricing Analysis
4.4 Pricing Analysis for Sipping Formula
4.5 List of Key Market Players in Top 5 Market
4.5.1 Major Market players in Germany, France, United Kingdom
5. Europe Enteral Nutrition Market – Key Market Dynamics
5.1 Europe Enteral Nutrition Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Increasing Prevalence of Gastrointestinal Diseases
5.2.2 Rising Cases of Malnutrition and Premature Births
5.3 Market Restraints
5.3.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Feeding Systems
5.4 Market Opportunities
5.4.1 Strategic Initiatives by Key Market Players
5.5 Future Trends
5.5.1 Standardized Formulations and Plant-Based Nutrition Products
5.6 Impact of Drivers and Restraints:
6. Europe Enteral Nutrition Market Analysis
6.1 Europe Enteral Nutrition Market Revenue (US$ Million), 2021–2031
6.2 Europe Enteral Nutrition Market Forecast and Analysis
6.3 Enteral and Parenteral Market Value (%)
7. Europe Enteral Nutrition Market Analysis – by Product Type
7.1 Nasogastric
7.1.1 Overview
7.1.2 Nasogastric: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.1.3 Standard
7.1.3.1 Overview
7.1.3.2 Standard: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.1.4 Disease Specific
7.1.4.1 Overview
7.1.4.2 Disease Specific: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Nasoenteral
7.2.1 Overview
7.2.2 Nasoenteral: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Sipping
7.3.1 Overview
7.3.2 Sipping: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Enteral Nutrition Market – Country Analysis
8.1 Europe
8.1.1 Europe Enteral Nutrition Market Breakdown by Countries
8.1.2 Europe Enteral Nutrition Market Revenue and Forecast and Analysis – by Country
8.1.2.1 Europe Enteral Nutrition Market Revenue and Forecast and Analysis – by Country
8.1.2.2 Germany: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8.1.2.2.1 Germany: Europe Enteral Nutrition Market Breakdown by Product Type
8.1.2.2.2 Germany: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
8.1.2.2.3 Germany: Europe Enteral Nutrition Market Breakdown by Standard By Calories
8.1.2.2.4 Germany: Europe Enteral Nutrition Market Breakdown by Isocaloric
8.1.2.2.5 Germany: Europe Enteral Nutrition Market Breakdown by Hypercaloric
8.1.2.2.6 Germany: Europe Enteral Nutrition Market Breakdown by Standard By Type
8.1.2.2.7 Germany: Europe Enteral Nutrition Market Breakdown by Standard By End User
8.1.2.3 United Kingdom: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8.1.2.3.1 United Kingdom: Europe Enteral Nutrition Market Breakdown by Product Type
8.1.2.3.2 United Kingdom: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
8.1.2.3.3 United Kingdom: Europe Enteral Nutrition Market Breakdown by Standard By Calories
8.1.2.3.4 United Kingdom: Europe Enteral Nutrition Market Breakdown by Isocaloric
8.1.2.3.5 United Kingdom: Europe Enteral Nutrition Market Breakdown by Hypercaloric
8.1.2.3.6 United Kingdom: Europe Enteral Nutrition Market Breakdown by Standard By Type
8.1.2.3.7 United Kingdom: Europe Enteral Nutrition Market Breakdown by Standard By End User
8.1.2.4 France: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8.1.2.4.1 France: Europe Enteral Nutrition Market Breakdown by Product Type
8.1.2.4.2 France: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
8.1.2.4.3 France: Europe Enteral Nutrition Market Breakdown by Standard By Calories
8.1.2.4.4 France: Europe Enteral Nutrition Market Breakdown by Isocaloric
8.1.2.4.5 France: Europe Enteral Nutrition Market Breakdown by Hypercaloric
8.1.2.4.6 France: Europe Enteral Nutrition Market Breakdown by Standard By Type
8.1.2.4.7 France: Europe Enteral Nutrition Market Breakdown by Standard By End User
8.1.2.5 Italy: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8.1.2.5.1 Italy: Europe Enteral Nutrition Market Breakdown by Product Type
8.1.2.5.2 Italy: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
8.1.2.5.3 Italy: Europe Enteral Nutrition Market Breakdown by Standard By Calories
8.1.2.5.4 Italy: Europe Enteral Nutrition Market Breakdown by Isocaloric
8.1.2.5.5 Italy: Europe Enteral Nutrition Market Breakdown by Hypercaloric
8.1.2.5.6 Italy: Europe Enteral Nutrition Market Breakdown by Standard By Type
8.1.2.5.7 Italy: Europe Enteral Nutrition Market Breakdown by Standard By End User
8.1.2.6 Spain: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8.1.2.6.1 Spain: Europe Enteral Nutrition Market Breakdown by Product Type
8.1.2.6.2 Spain: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
8.1.2.6.3 Spain: Europe Enteral Nutrition Market Breakdown by Standard By Calories
8.1.2.6.4 Spain: Europe Enteral Nutrition Market Breakdown by Isocaloric
8.1.2.6.5 Spain: Europe Enteral Nutrition Market Breakdown by Hypercaloric
8.1.2.6.6 Spain: Europe Enteral Nutrition Market Breakdown by Standard By Type
8.1.2.6.7 Spain: Europe Enteral Nutrition Market Breakdown by Standard By End User
8.1.2.7 Czech Republic: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8.1.2.7.1 Czech Republic: Europe Enteral Nutrition Market Breakdown by Product Type
8.1.2.7.2 Czech Republic: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
8.1.2.7.3 Czech Republic: Europe Enteral Nutrition Market Breakdown by Standard By Calories
8.1.2.7.4 Czech Republic: Europe Enteral Nutrition Market Breakdown by Isocaloric
8.1.2.7.5 Czech Republic: Europe Enteral Nutrition Market Breakdown by Hypercaloric
8.1.2.7.6 Czech Republic: Europe Enteral Nutrition Market Breakdown by Standard By Type
8.1.2.7.7 Czech Republic: Europe Enteral Nutrition Market Breakdown by Standard By End User
8.1.2.8 Rest of Europe: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8.1.2.8.1 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Product Type
8.1.2.8.2 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
8.1.2.8.3 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Standard By Calories
8.1.2.8.4 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Isocaloric
8.1.2.8.5 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Hypercaloric
8.1.2.8.6 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Standard By Type
8.1.2.8.7 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Standard By End User
9. Industry Landscape
9.1 Overview
9.2 Growth Strategies in Europe Enteral Nutrition Market
9.3 Organic Growth Strategies
9.3.1 Overview
9.4 Inorganic Growth Strategies
9.4.1 Overview
10. Company Profiles
10.1 Nestle SA
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Danone SA
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Abbott Laboratories
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Royal FrieslandCampina NV
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Fresenius SE & Co KGaA
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 B Braun SE
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Reckitt Benckiser Group Plc
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Kate Farms Inc
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Dr Schar AG
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Fonterra Co-Operative Group Ltd
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Products and Services
10.10.4 Financial Overview
10.10.5 SWOT Analysis
10.10.6 Key Developments
10.11 Arla Foods amba
10.11.1 Key Facts
10.11.2 Business Description
10.11.3 Products and Services
10.11.4 Financial Overview
10.11.5 SWOT Analysis
10.11.6 Key Developments
10.12 Perrigo Co Plc
10.12.1 Key Facts
10.12.2 Business Description
10.12.3 Products and Services
10.12.4 Financial Overview
10.12.5 SWOT Analysis
10.12.6 Key Developments
10.13 Charing Cross Scientific AS
10.13.1 Key Facts
10.13.2 Business Description
10.13.3 Products and Services
10.13.4 Financial Overview
10.13.5 SWOT Analysis
10.13.6 Key Developments
10.14 Bexen Medical
10.14.1 Key Facts
10.14.2 Business Description
10.14.3 Products and Services
10.14.4 Financial Overview
10.14.5 SWOT Analysis
10.14.6 Key Developments
11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
List of Tables
Table 1. Europe Enteral Nutrition Market Segmentation
Table 2. Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Table 3. Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 4. Sipping: Europe Enteral Nutrition Market, By Type (US$ Mn)
Table 5. Sipping: Europe Enteral Nutrition Market, By Standadr by Calories (US$ Mn)
Table 6. Sipping: Europe Enteral Nutrition Market, By Isocaloric (US$ Mn)
Table 7. Sipping: Europe Enteral Nutrition Market, By Hypercaloric (US$ Mn)
Table 8. Sipping: Europe Enteral Nutrition Market, By Standard by Type (US$ Mn)
Table 9. Sipping: Europe Enteral Nutrition Market, By Standard End User (US$ Mn)
Table 10. Sipping: Top 5 Europe Enteral Nutrition Markets (US$ Mn)
Table 11. Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Country
Table 12. Germany: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 13. Germany: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Nasogastric Type
Table 14. Germany: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Calories
Table 15. Germany: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Isocaloric
Table 16. Germany: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Hypercaloric
Table 17. Germany: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Type
Table 18. Germany: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By End User
Table 19. United Kingdom: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 20. United Kingdom: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Nasogastric Type
Table 21. United Kingdom: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Calories
Table 22. United Kingdom: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Isocaloric
Table 23. United Kingdom: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Hypercaloric
Table 24. United Kingdom: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Type
Table 25. United Kingdom: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By End User
Table 26. France: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 27. France: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Nasogastric Type
Table 28. France: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Calories
Table 29. France: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Isocaloric
Table 30. France: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Hypercaloric
Table 31. France: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Type
Table 32. France: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By End User
Table 33. Italy: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 34. Italy: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Nasogastric Type
Table 35. Italy: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Calories
Table 36. Italy: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Isocaloric
Table 37. Italy: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Hypercaloric
Table 38. Italy: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Type
Table 39. Italy: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By End User
Table 40. Spain: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 41. Spain: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Nasogastric Type
Table 42. Spain: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Calories
Table 43. Spain: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Isocaloric
Table 44. Spain: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Hypercaloric
Table 45. Spain: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Type
Table 46. Spain: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By End User
Table 47. Czech Republic: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 48. Czech Republic: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Nasogastric Type
Table 49. Czech Republic: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Calories
Table 50. Czech Republic: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Isocaloric
Table 51. Czech Republic: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Hypercaloric
Table 52. Czech Republic: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Type
Table 53. Czech Republic: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By End User
Table 54. Rest of Europe: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 55. Rest of Europe: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Nasogastric Type
Table 56. Rest of Europe: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Calories
Table 57. Rest of Europe: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Isocaloric
Table 58. Rest of Europe: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Hypercaloric
Table 59. Rest of Europe: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Type
Table 60. Rest of Europe: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By End User
Table 61. Recent Organic Growth Strategies in Europe Enteral Nutrition Market
Table 62. Recent Inorganic Growth Strategies in the Europe Enteral Nutrition Market
Table 63. Glossary of Terms, Europe Enteral Nutrition Market
List of Figures
Figure 1. Europe Enteral Nutrition Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Enteral Nutrition Market Revenue (US$ Million), 2021–2031
Figure 5. Europe Enteral Nutrition Market Share (%) – by Product Type, 2023 and 2031
Figure 6. Nasogastric: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Standard: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Disease Specific: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. Nasoenteral: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Sipping: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Others: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Europe Enteral Nutrition Market Breakdown by Key Countries, 2023 and 2031 (%)
Figure 13. Germany: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. United Kingdom: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. France: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Italy: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. Spain: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. Czech Republic: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Rest of Europe: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Growth Strategies in Europe Enteral Nutrition Market
- Nestlé
- Danone S.A.
- Abbott Laboratories
- FrieslandCampina
- Fresenius SE and Co. KGaA
- B. Braun SE
- Dr. Schär AG
- Arla Food
- Reckitt Benckiser
- Perrigo Company PLC
- Fonterra Co-operative Group Limited
- Kate Farms
- Nutritional Medicinals, LLC
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe enteral nutrition market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe enteral nutrition market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution